PUBLISHER: 360iResearch | PRODUCT CODE: 1587248
PUBLISHER: 360iResearch | PRODUCT CODE: 1587248
Cognitive & Memory Enhancer Drugs Market by Drug Type (Adderall, Aricept, Exelon), Application (Academic Performance, Athletic Performance, Disease Treatment) - Global Forecast 2025-2030
The Cognitive & Memory Enhancer Drugs Market was valued at USD 5.93 billion in 2023, expected to reach USD 6.49 billion in 2024, and is projected to grow at a CAGR of 9.57%, to USD 11.25 billion by 2030.
Cognitive and memory enhancer drugs, often referred to as nootropics, are pharmaceuticals and supplements designed to improve mental performance by various mechanisms, targeting memory, attention, motivation, and other executive functions. The necessity for these drugs is underscored by increasing workloads and the aging population, prompting demand for enhanced cognitive function in both young professionals seeking an edge in competitive environments and the elderly aiming to mitigate age-related cognitive decline. End-use applications span across healthcare for treating neurological disorders such as Alzheimer's and ADHD, to use in academia and the workforce for performance enhancement. Market growth is influenced by factors such as rising awareness about mental health, technological advancements in pharmaceutical formulations, and increased investment in research and development by key players. Opportunities exist in developing compounds with fewer side effects, expanding natural and organic product lines, and targeting emerging markets in Asia and Latin America.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 5.93 billion |
| Estimated Year [2024] | USD 6.49 billion |
| Forecast Year [2030] | USD 11.25 billion |
| CAGR (%) | 9.57% |
However, stringent regulatory frameworks and ethical concerns over the non-medical use of cognitive enhancers pose significant challenges. Side effects associated with long-term usage and the potential for misuse further hinder growth. The best areas for innovation include developing integrative solutions that combine pharmacological advancements with digital therapeutics, exploring personalized medicine approaches through genetic profiling, and enhancing delivery mechanisms for improved bioavailability. The market is competitive, marked by rapid technological exchange and a constant influx of start-ups challenging established pharmaceutical giants. Innovation and research focused on sustainable and ethically developed products will likely drive progress and acceptance. To capitalize on these opportunities, companies should invest in strategic partnerships with academia and invest in marketing to educate potential consumers on the benefits and safety of cognitive enhancers. The dynamic and evolving nature of the market demands agility and continuous adaptation to shifting consumer expectations and regulatory landscapes.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cognitive & Memory Enhancer Drugs Market
The Cognitive & Memory Enhancer Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing prevalence of people suffering from neurodegenerative disorders
- Rise in geriatric population
- Increasing consideration of cognitive and memory enhancer drugs for academic and athletic applications
- Market Restraints
- High cost of drug development
- Market Opportunities
- Development of novel drugs and therapies
- Government approval for new drug development
- Market Challenges
- Risk of side effects
Porter's Five Forces: A Strategic Tool for Navigating the Cognitive & Memory Enhancer Drugs Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cognitive & Memory Enhancer Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Cognitive & Memory Enhancer Drugs Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cognitive & Memory Enhancer Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Cognitive & Memory Enhancer Drugs Market
A detailed market share analysis in the Cognitive & Memory Enhancer Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cognitive & Memory Enhancer Drugs Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cognitive & Memory Enhancer Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Cognitive & Memory Enhancer Drugs Market
A strategic analysis of the Cognitive & Memory Enhancer Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Cognitive & Memory Enhancer Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amway Corporation, Biogen Inc., Eisai Co., Ltd., Eli Lilly and Company, Glanbia PLC, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited., Teva Pharmaceutical Industries Ltd., Unilever PLC, and WebMD LLC.
Market Segmentation & Coverage
This research report categorizes the Cognitive & Memory Enhancer Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Drug Type, market is studied across Adderall, Aricept, Exelon, Namenda, Provigil, Razadyne, and Ritalin.
- Based on Application, market is studied across Academic Performance, Athletic Performance, and Disease Treatment.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of people suffering from neurodegenerative disorders
- 5.1.1.2. Rise in geriatric population
- 5.1.1.3. Increasing consideration of cognitive and memory enhancer drugs for academic and athletic applications
- 5.1.2. Restraints
- 5.1.2.1. High cost of drug development
- 5.1.3. Opportunities
- 5.1.3.1. Development of novel drugs and therapies
- 5.1.3.2. Government approval for new drug development
- 5.1.4. Challenges
- 5.1.4.1. Risk of side effects
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Cognitive & Memory Enhancer Drugs Market, by Drug Type
- 6.1. Introduction
- 6.2. Adderall
- 6.3. Aricept
- 6.4. Exelon
- 6.5. Namenda
- 6.6. Provigil
- 6.7. Razadyne
- 6.8. Ritalin
7. Cognitive & Memory Enhancer Drugs Market, by Application
- 7.1. Introduction
- 7.2. Academic Performance
- 7.3. Athletic Performance
- 7.4. Disease Treatment
8. Americas Cognitive & Memory Enhancer Drugs Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Cognitive & Memory Enhancer Drugs Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Cognitive & Memory Enhancer Drugs Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. AbbVie Inc.
- 2. Amway Corporation
- 3. Biogen Inc.
- 4. Eisai Co., Ltd.
- 5. Eli Lilly and Company
- 6. Glanbia PLC
- 7. Johnson & Johnson Services, Inc.
- 8. Novartis AG
- 9. Pfizer Inc.
- 10. Sanofi S.A.
- 11. Takeda Pharmaceutical Company Limited.
- 12. Teva Pharmaceutical Industries Ltd.
- 13. Unilever PLC
- 14. WebMD LLC
LIST OF FIGURES
- FIGURE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 11. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 13. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 19. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. COGNITIVE & MEMORY ENHANCER DRUGS MARKET DYNAMICS
- TABLE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ADDERALL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ARICEPT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY EXELON, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NAMENDA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PROVIGIL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RAZADYNE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RITALIN, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ACADEMIC PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATHLETIC PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 26. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 27. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 28. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 29. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 30. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 31. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 32. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 33. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 34. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 35. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 36. AUSTRALIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 37. AUSTRALIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 38. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 39. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 40. INDIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 41. INDIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 42. INDONESIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 43. INDONESIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 44. JAPAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 45. JAPAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 46. MALAYSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 47. MALAYSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 48. PHILIPPINES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 49. PHILIPPINES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 50. SINGAPORE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 51. SINGAPORE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 52. SOUTH KOREA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 53. SOUTH KOREA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 54. TAIWAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 55. TAIWAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 56. THAILAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 57. THAILAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 58. VIETNAM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 59. VIETNAM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 60. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 61. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 62. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 63. DENMARK COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 64. DENMARK COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 65. EGYPT COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 66. EGYPT COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 67. FINLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 68. FINLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 69. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 70. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 71. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 72. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 73. ISRAEL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 74. ISRAEL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 75. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 76. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 77. NETHERLANDS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 78. NETHERLANDS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 79. NIGERIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 80. NIGERIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 81. NORWAY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 82. NORWAY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 83. POLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 84. POLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 85. QATAR COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 86. QATAR COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 87. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 88. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 89. SAUDI ARABIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 90. SAUDI ARABIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 91. SOUTH AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 92. SOUTH AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 93. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 94. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 95. SWEDEN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 96. SWEDEN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 97. SWITZERLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 98. SWITZERLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 99. TURKEY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 100. TURKEY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 101. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 102. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 103. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 104. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 105. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 106. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
